YBX1 and metabolic dysfunction-associated steatotic liver disease: Previous studies have shown that YB1 regulates liver lipid metabolism via the Wnt/β-catenin signaling pathway [15], and that INHBE and P4HA1 are key hub genes in NAFLD [29].